Actinium Pharmaceuticals Story Overview

ATNM -- USA Stock  

USD 0.44  0.01  2.33%

Macroaxis does not monitor all media channels or aggregates social signals for Actinium Pharmaceuticals. But even though we do not provide professional-grade financial sentiment analysis on Actinium Pharmaceuticals, we do publish noise-free headlines that can be used to derive useful patterns or even a trading strategy for Actinium Pharmaceuticals. Check also Actinium Pharmaceuticals Hype Analysis, Actinium Pharmaceuticals Correlation and Actinium Pharmaceuticals Performance.
Acquisition or disposition of Actinium Pharmaceuticals securities by Nitya Ray
Filed transaction by Actinium Pharmaceuticals officer. Acquisition or disposition under rule 16b-3

Actinium Pharmaceuticals Inc insider trading alert for acquisition or disposition of series b warrants by Nitya Ray, Executive VP, on March 8, 2018. This event was filed by Actinium Pharmaceuticals with SEC on 2018-03-08. Statement of changes in beneficial ownership - SEC Form 4. Nitya Ray is currently serves as executive vice president head - product development, manufacturing and supply chain of Actinium Pharmaceuticals

Story Momentum

This media report from MacroaxisInsider distributed on March 8, 2018 was a factor to the next trading day price decrease.The overall trading delta against the next closing price was 0.02% . The overall trading delta when the story was published against the current closing price is 4.63% .

Similar stores for Actinium Pharmaceuticals

What Are The Technicals Telling Us About Actinium Pharmaceuticals Inc - Stock News OracleNews Oracle News
What Are The Technicals Telling Us About Actinium Pharmaceuticals Inc Stock News OracleActinium Pharmaceuticals Inc shares have experienced bearish momentum as the Average True Range of the shares have trended downward over the ...
few days ago at http://flecha123.com 
Actinium Pharmaceuticals Inc Sentiment Report - Flecha 123
news
Actinium Pharmaceuticals Inc Sentiment Report Flecha 123Actinium Pharmaceuticals Inc institutional sentiment decreased to 1 in 2018 Q2. Its down -0.50, from 1.5 in 2018Q1. The ratio fall, as 13 ...
over a week ago at http://nasdaqclick.com 
Overview of Price Moves Actinium Pharmaceuticals, Inc. - Nasdaq Click
nasdaq News
Overview of Price Moves Actinium Pharmaceuticals, Inc. Nasdaq ClickActinium Pharmaceuticals, Inc. stock price ended its day with gain 2.67 percent and finalized at the price of 0.58, its 52 week- peak value and changed ...
over two weeks ago at http://thewellesleysnews.com 
Analyst Research and Ratings Actinium Pharmaceuticals, Inc. , Limbach Holdings, Inc. - Analyst Journal
news
Analyst Research and Ratings Actinium Pharmaceuticals, Inc. , Limbach Holdings, Inc. Analyst JournalActinium Pharmaceuticals, Inc. tinted loss of -3.35 percent to US0.43. The volume of 0.37 Million shares climbed down over an trading ...
over two weeks ago at http://finherald.com 
Deep Finance Survey of Actinium Pharmaceuticals, Inc.
news
Financial HeraldLegal General Group Plc Cut Its Nasdaq Holding Actinium Pharmaceuticals Sentiment Is 1 The FinReviewerFull coverage
over three weeks ago at http://nasdaqclick.com 
Actinium Pharmaceuticals, Inc. Noteworthy Buzzer
nasdaq News
Nasdaq Click Full coverage
over three weeks ago at http://stocknewsgazette.com 
Which is more compelling pick right now Actinium Pharmaceuticals, Inc. , Cloud Peak Energy Inc.
news
StockNewsGazetteFull coverage
over a month ago at http://www.fairfieldcurrent.com 
Actinium Pharmaceuticals Inc Holdings Raised by Renaissance Technologies LLC
news
Fairfield CurrentShort Interest in Actinium Pharmaceuticals Inc Declines By 5.8 Baseball Daily NewsFull coverage
over a month ago at http://nasdaqclick.com 
Take a look at Price Fluctuations Actinium Pharmaceuticals, Inc.
nasdaq News
Nasdaq Click Full coverage
over a month ago at http://www.stocksequity.com 
Movers to Watch Actinium Pharmaceuticals, Inc. , Akers Biosciences, Inc.
news
Stocks Equity Full coverage
over a month ago at http://www.finbulletin.com 
Gunning for the success MT Bank Corporation , Actinium Pharmaceuticals, Inc.
news
FinBulletinFree Report for MTB - Zacks.com ZacksFull coverage
over three months ago at http://postanalyst.com 
Forget What Wall Street Says Actinium Pharmaceuticals, Inc. , Magna International Inc.
news
Post AnalystFull coverage
over three months ago at http://www.thestocksnews.com 
Actinium Pharmaceuticals, Inc. stock returned 66.46 percent up Monthly Gainer
news
The Stocks News Full coverage

Current Valuation

Current Valuation Comparative Analysis

  Current Valuation 
      Actinium Pharmaceuticals Comparables 
Actinium Pharmaceuticals is currently under evaluation in current valuation category among related companies. Enterprise Value is a firm valuation proxy that approximates current market value of a company. It is typically used to determine takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that company has on its balance sheet. When takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Check also Actinium Pharmaceuticals Hype Analysis, Actinium Pharmaceuticals Correlation and Actinium Pharmaceuticals Performance. Please also try Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Search macroaxis.com